Furthermore, this analysis showed that patients could be divided into two main subsets based on the expression of a subset of proteins showing generally high levels when comparing the total AML and CD34+ cell populations (the lower protein main cluster; see left part of Figure 5). This evidence concerns the gene CD34 and acute myeloid leukemia.